It has been reported that epigenetic silencing of miR-107 can regulate the expression of cyclin-dependent kinase 6 in pancreatic cancer [15]; while interfering miR-409-3p promotes tumour growth, the epithelial-to-mesenchymal transition (EMT) and bone metastasis [38]. The gene discussed is CDK6; the disease is pancreatic neoplasm.